REVA Medical, LLC today announced primary endpoint results from the MOTIV BTK randomized pivotal clinical trial evaluating ...
Adjunctive corticosteroid therapy accelerated resolution of hypoxemia in hospitalized adults with Mycoplasma pneumoniae ...
Post-thrombotic syndrome is common after deep-vein thrombosis and can cause severe symptoms involving the limbs that impair patients’ activity and quality of life. Endovascular therapy can ...
The adrenergic antagonist improved near vision in adults with presbyopia, with over 20 hours of improvement from a single ...
A randomized trial in a large economics course found that AI-mediated feedback improved students' revisions when teaching ...
A landmark trial presented at ESCMID Global 2026 shows that improving oral hygiene for hospital patients can reduce the risk ...
Axena Health, Inc., a women's health company redefining the standard of care for pelvic health conditions through clinically proven, non-invasive treatments, today announced a new publication entitled ...
Rivus Pharmaceuticals has dosed the first patients in the AMPLIFY Phase II clinical trial evaluating HU6, an investigational ...
Idiopathic normal-pressure hydrocephalus is a neurologic disorder characterized by impaired gait, balance, cognition, and bladder control in older adults. The disorder is treated with shunt surgery, ...
The traditional gold standard of clinical trials with a randomized, placebo-controlled design involving hundreds of patients ...
Thought LeadersAoife Hayes, Kevin O'Regan & Julie ScanlonClinical Trials Assitant, Operations Manager & Quality Assurance ManagerAtlantia Clinical Trials Food clinical trials may not be as familiar to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results